Related Experiment Video
Updated: May 13, 2026
05:48
Left Coronary Artery Ligation: A Surgical Murine Model of Myocardial Infarction
Published on: August 9, 2022
Unprotected left main coronary artery disease. Surgical therapy
J Cremer1, J Schöttler, A Haneya
1Department of Cardiovascular Surgery, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Arnold-Heller-Strasse 3, Kiel, Germany. jcremer@kielheart.uni-kiel.de
Herz
|March 9, 2013
Summary
Coronary artery bypass grafting (CABG) is the recommended treatment for unprotected left main coronary artery (ULMCA) disease, offering excellent long-term outcomes. Further research is needed to compare CABG with percutaneous coronary intervention in real-world scenarios.
Area of Science:
- Cardiology
- Cardiovascular Surgery
Background:
- Unprotected left main coronary artery (ULMCA) disease requires careful treatment consideration.
- Coronary artery bypass grafting (CABG) is currently the guideline-recommended first-line therapy for ULMCA disease.
- CABG demonstrates excellent long-term results irrespective of lesion complexity or comorbidities.
Purpose of the Study:
- To review the current evidence regarding treatment options for ULMCA disease.
- To highlight the need for robust clinical trials comparing revascularization strategies for ULMCA lesions.
Main Methods:
- Review of existing randomized controlled trials (RCTs) and guidelines.
- Analysis of comparative effectiveness of CABG versus percutaneous coronary intervention (PCI) for ULMCA disease.
Main Results:
- Existing RCTs on PCI for ULMCA are often underpowered.
- PCI may show comparable results to CABG in less complex ULMCA lesions.
- CABG remains the established treatment with superior long-term outcomes.
Conclusions:
- An interdisciplinary approach is crucial for managing ULMCA disease.
- Further large-scale, all-comers RCTs are essential to provide real-world data on ULMCA revascularization.
- Current guidelines support CABG as the primary treatment for ULMCA disease.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:24Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:26Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...